Focused Ultrasound Therapy
Focused ultrasound is an early-stage, noninvasive, therapeutic technology with the potential to improve the quality of life and decrease the cost of care for patients with endometrial tumors. This novel technology focuses beams of ultrasound energy precisely and accurately on targets in the body without damaging surrounding normal tissue.
How it Works
Where the beams converge, focused ultrasound produces precise ablation (thermal destruction of tissue) enabling endometrial tumors to be treated without surgery.
The primary options for treatment of endometrial cancer include surgery, chemotherapy, radiation therapy, targeted treatments and combinations.
For certain patients, focused ultrasound could provide a noninvasive alternative to surgery with less risk of complications – such as surgical wound healing or infection – at a lower cost. Focused ultrasound can reach the desired target without damaging surrounding tissue, and enhance chemotherapy dose for the target, with less impact to the rest of the patient. It can also be repeated, if necessary.
A clinical trial in the UK is exploring recurrent gynecology cancers, including endometrial cancer.
A recently completed clinical trial in the UK assessed using focused ultrasound to treat symptomatic (pain or bleeding) recurrent pelvic malignancy when conventional treatment options are not available.
Regulatory Approval and Reimbursement
Focused ultrasound treatment for endometrial cancer is not yet approved by regulatory bodies or covered by medical insurance companies.
Guan L, Xu G. Destructive effect of HIFU on rabbit embedded endometrial carcinoma tissues and their vascularities. Oncotarget. 2017 Mar 21;8(12):19577-19591. doi: 10.18632/oncotarget.14751.
Sri T, Steren AJ, Stratton P. Endometrial Cancer: Hidden Pathology in a Patient with Abnormal Uterine Bleeding and Known Leiomyoma. Gynecol Obstet Invest. 2015;80(4):272-5. doi: 10.1159/000370002.
Agdi M, Tulandi T. Minimally invasive approach for myomectomy. Semin Reprod Med. 2010 May;28(3):228-34. doi: 10.1055/s-0030-1251479. Review.
Click here for additional references from PubMed.